PTS help our customers in developing tailored delivery technologies to solve drug delivery problems of actives via encapsulation (excipients) or conjugation (Drug Substance) modalities with simple, reproducible and scalable chemical and formulation processes.
State of the art facilities fully devoted to the GMP manufacturing of polyamino acid-based Drug Substances and Drug Product to support clinical development and commercialization.
Consistent reproducibility across the different project stages and scales. Excellent feedback from regulatory agencies on the CMC packages delivered to date from both EMA and FDA.
Our Skilled technical workforce and innovative business development team will get to a finish line faster, providing both cost-efficient and mitigated risk approach.